Hiv Aids Articles & Analysis
52 news found
Airfinity announces today the launch of Airfinity IDA (Infectious Disease Analytics) 360, a new platform that will provide a comprehensive overview of vaccine and therapeutics candidates across the full infectious disease landscape. Airfinity IDA 360, a first-of-its-kind product in the health analytics market, will be a centralised source of competitive intelligence, providing clear and near ...
The Acuitas team is currently working on therapeutics focused on addressing cancer, HIV/AIDS, rabies, tuberculosis, malaria and other serious ...
The Acuitas team is currently working on therapeutics focused on addressing cancer, HIV/AIDS, rabies, tuberculosis, malaria and other serious ...
Source: AIDS info, Global data on HIV epidemiology and response; https://aidsinfo.unaids.org/ Accessed on 6 March 2022 Frontier Biotechnologies is commercializing Aikening® in Azerbaijan through its partnership with R-Pharm, a leading pharmaceutical company headquartered in Russia. ...
” Together, the preclinical data on the HIV arenaviral program support clinical development as a component of a potential HIV therapeutic. ...
Paul’s Hospital rank among the world’s best in their fields, including heart, lung, renal, HIV/AIDS, and seniors care. Since its founding in 1894, St. Paul’s Hospital has provided innovative and compassionate patient care. ...
Challenging treatment pricing and accessibility Cipla changed the face of the HIV/Aids pandemic during its most severe phase more than 20 years ago, by dramatically slashing the prices of antiretrovirals to less than $1 a day, in comparison to the prevailing yearly treatment cost of $12,000 per patient. This revolutionised ...
Why HIV Testing is Important HIV Testing is critical to reducing its spread. ...
ByFluxergy
The TALENT study (TALENT) findings, which were presented at the 11th International AIDS Society (IAS) Conference on HIV Science, showed that a two-drug regimen was as effective and safe as multi-drug therapies TALENT is the world's first phase III clinical trial of the new long-acting HIV-1 fusion inhibitor, Aikening® (generic name: ...
· CD4 as A Target for SARS-CoV-2 Antibody Development Ibalizumab has been approved by the Food and Drug Administration to treat HIV/AIDS, and it has been studied recently to be a potential treatment for SARS-CoV-2. ...
About Lauren Sciences LLC Lauren Sciences is a private, New York biotechnology company that leads in breakthrough innovation with the development of transformative V-Smart™ Nanomedicines for brain diseases, including CNS, neurodegenerative and rare/orphan brain diseases, such as GBM, NPC, ALS, Neuro-AIDS, Parkinson's, Alzheimer's and LSDs, among others, as well as ...
"One of our Foundation's major goals is to find a disease-modifying therapy for HIV/AIDS," said Ken Rapkin, Program Officer of Campbell. "The challenges associated with the delivery of HIV drugs through the BBB represent a critical unmet need in the field of AIDS research. This project’s success bodes well for the future of ...
Integrated Medical Industries Limited (IMIL), a Nigerian medical equipment maker, has contracted with Clarke Energy to install a captive power plant on the front line of the battle against malaria and aids. Double first: The manufacturing plant is the first World Health Organization (WHO) Performance Quality Safety (PQS) pre-qualified plant in Western Sub-Saharan Africa. ...
Investigators discuss in "a(1)Proteinase Inhibitor Regulates CD4 Lymphocyte Levels and Is Rate Limiting in HIV-1 Disease" new findings in HIV/AIDS. According to the authors of recent research from New York City, New York, "The regulation of adult stem cell migration through human hematopoietic tissue involves the chemokine CXCL12 (SDF-1) and its ...
The goals were designed to draw attention to problems of the developing world that persisted despite billions of global aid directed at solving them. Several goals were health-focused — for example, MDG 4 aims to reduce child mortality, MDG 5 to improve maternal health, and MDG 6 to combat HIV/AIDS, malaria and other infectious diseases. ...
These countries also have some of the world’s highest HIV prevalences. South Africa, with 5.6 million people infected (11 percent of the total population), has more people living with HIV than any other country in the world. ...
Delayed test results often mean HIV patients in Mozambique fail to get timely treatment, but new technology is reducing the need to send tests to far away laboratories, and speeding up test results and HIV treatment. ...
Issues like domestic violence, adult literacy, teenage pregnancy, sexual and reproductive health and HIV and AIDS. In addition, portions of the drama are dedicated to raising awareness of new laws and state services that are designed to support the welfare of the family and promote the empowerment of women. ...
, Special Olympics, Boys & Girls Clubs of America, UNICEF, the Make-A-Wish Foundation, and the Global Business Coalition on HIV/AIDS, Malaria and ...
The continuation of this project, which was initiated in 2005 in Mexico, will create a path for expansion and sustainability of the model in Latin America. "Addressing human rights in our HIV programming is fundamental to the community response to HIV," said Alvaro Bermejo, Executive Director of the International HIV/AIDS ...